TAXIS PHARMACEUTICALS

TAXIS Pharmaceuticals is a privately held biopharmaceutical company dedicated to developing compounds to target the growing threat of antimicrobial resistance, including antibacterial and antiviral resistance. We are currently focused on antibiotic agents that employ novel mechanisms of action distinct from those currently in clinical use. Our team’s expertise in discovery chemistry, combined with our spirit of innovation, allows us to quickly pinpoint promising compounds that exhibit the key properties required for a clinical drug candidate.